VALIDATION OF THE TUNISIAN VERSIONS OF BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX (BASFI) AND DISEASE ACTIVITY INDEX (BASDAI)

##plugins.themes.academic_pro.article.sidebar##

Published Dec 2, 2009
Download
pdf
Vol. 87 No. 8 (2009): Issue Aug 2009

##plugins.themes.academic_pro.article.main##

Mohamed Montacer Kchir
Wafa Hamdi
Samir Kochbati
Dhouha Azzouz
Lilia Daoud
Kaouthar Saadellaoui
Mohamed Mehdi Ghannouchi
Dhia Kaffel
Abdelmajid Ben Hamida
Béchir Zouari

Abstract

Background: The Bath Ankylosing Spondylitis Functional Index (BASFI) and the Bath Ankylosing Spondylitis Disease Activity (BASDAI) are the most commonly used instruments to evaluate respectively functioning and disease activity in ankylosing spondylitis (AS).
Objective : The aim of this study was to translate, adapt and validate these instruments into the Tunisian language. Methods. - The studied population consisted of 68 AS patients (59 males and 9 females). Their mean age was 37.9 years (range: 18-76). The mean disease duration was 13.6 years (range: 1-40).After translation and retranslation the BASFI and BASDAI questionnaires were administrated to the patients and tested for reliability, internal consistency and construct validity.
Results : The reproducibility of the indices BASFI and BASFAI was good, the intraclass correlation coefficient for reliability was 0.96 (CCI:0.93 – 0.97) for the BASFI and 0.93 (CCI:0.90 – 0.97) for the BASDAI, and the coefficient of internal consistency (Cronbach’s alpha) was 0.91 for BASFI and 0.90 for BASDAI. Concerning construct validity, both questionnaires were significantly correlated to each other, to the disease-specific instruments (BASG-s, BASMI, BASRI, ASQoL) and to all domains of the SF-36.
Conclusion: the Tunisian versions of the BASFI and the BASDAI preserve the metrological properties of the original versions and were easy to use for the assessment of disease status in ankylosing spondylitis.

Keywords:

Ankylosing spondylitis, Spondylarthropathy, Functional index, BASFI, Disease activity index, BASDAI

##plugins.themes.academic_pro.article.details##

References

  1. Khan MA . Ankylosing spondylitis- the history of medical therapies. Clin Exp Rheumatol 2002; 20 [Suppl 6]:3-5
  2. Van der Heijde D, Calin A, Dougados M, et al. Selection of instruments in the core set for DC-ART, SMARD, physical therapyand clinical record keeping in ankylosing spondylitis: progress report of the ASAS working group. J Rheumatol 1999; 26:951-4
  3. Van der Heijde D, Dougados M, Davis J, et al. Assessment in ankylosing spondylitis international working group/spondylitis association of America recommandationfor conducting clinical trials in ankylosing spondylitis. Arthritis Rheum 2005; 52(2):386-94
  4. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21:2281-5.
  5. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21:2286-91
  6. Moll JM. New criteria for the diagnosis of ankylosing spondylitis. Scand J Rheumatol 1987; 65 [Suppl]:12-24.
  7. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BASG-s). Br J Rheumatol 1996; 35:66-71.
  8. Jenkinson TR, Mallorie PA, Whitelock HC, et al. Defining spine mobility in ankylosing spondylitis: The Bath Ankylosing Spondylitis Metrology Index (BASMI). J Rheumatol 1994; 21:1694-8.
  9. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A at al.. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003; 62:127-32
  10. MacKay K, Mack C, Brophy S et al. The Bath Ankylosing Spondylitis Radiology Index: a new, validated approach to disease assessment. Arthritis Rheum 1998;41:2263-70.
  11. Doward LC, Spoorenberg A, Cook SA, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003; 62: 20-6.
  12. Coons SJ, Abdulmohsin SA, Draugalis JR, Hays RD. Reliability of an Arabic version of the Rand-36 Health Survey and Its Equivalence to the US-English Version. Medical Care 1998; 36 : 428-32
  13. Guillemin F, Bombardier C, Beaton D. Cross cultural adaptation of health related quality of life measures:literature review and proposed guidelines.J Clin Epidemiol 1993;46:1417- 32
  14. Cronstedt H, Waldner A, Stenströom C.H. The Swedish version of the Bath ankylosing spondylitis functional index. Scand J of Rheumatol 1999; 28: 1-9
  15. Heikkilä S,Viitanen J.V, Kautianen H, Kauppi M. Evaluation of the Finnish version of the Functional Indices BASFI and DFI in Spondylarthropathy. Clin Rheumatol 2000;19: 464-9
  16. 16- Carduel MH, Londono JD, Gutiérrez E, Pächeco-Tena C, Vazquz-Mellado J, Burgos-VargasR. Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index ( BASFI), the Bath Ankylosing Spondylitis Disease Activity. Index (BASDAI) and the Dougados Functional Index ( DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 2003;21 :451-8
  17. Huseyin T, E. Ozer, Tunay Sarpel, Bozkurt Gulek, Z. Nazan Alparslan, Eren Erken. The Turkish version of the Bath Ankylosing Spondylitis. Function Index : reliability and validity. Clin Rheumatol 2005; 24: 123-8
  18. Salaffi F, Stancati A, Silvestri A, Carotti M, Grassi W. alidation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis. Reumatismo 2005; 57 : 161-73
  19. Chatzitheodorou D, Kabitsis C, Papadopoulos NG, Galanopoulou V. Evaluation of the Greek version of the Bath Ankylosing Spondylitis Functional Index : reliability, validity, and factor analysis. Clin Exp Rheumatol 2007; 25 :571-6
  20. Pedersen OB, Hansen GO, Svendsen AJ, Ejstrup L, Junker P. Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish. Scand J Rheumatol 2007; 36: 22-7
  21. Calin A, Nakache J, Gueguen A, Zeidler H, Mielans H, Dougados M. Outcome variables in ankylosing spondylitis: Evaluation of their relevance and discriminant capacity. J Rheumatol 1999; 26: 975-9
  22. Claudepierre H, Sibilia J, Goupille P, Flipo RM, Wendling D, Eulry F. Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondylarthropathy. J Rheumatol 1997; 24: 1957-9
  23. Waldner A, Cronstedt H, Stenströom C.H. The Swedish version of the Bath ankylosing spondylitis disease activity index.Reliability and validity. Scand J of Rheumatol 1999;28:10-6
  24. Brand J, Westhoff G, Rudwaleit M, et al. Adaptation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany. Z Rheumatol 2003; 62 : 264-73
  25. Park HJ, Kim S, Lee JE, Jun JB, Bae SC. The reliability and validity of a Korean translation of the BASDAI in Korean patients with ankylosing spondylitis. Value Heath 2008; 11 (Suppl) 1: S99 - 104
  26. Spoorenberg A, de Vlam K, Van der Heijde D, de Klerk E, Dougados M, Mielants H. Radiologic scoring mrthods in ankylosing spondylitis: reliability and sensitivity to change over one year. J Rheumatol 1999;26: 997-1002.